English
Home > Products > 3-oxo-1,3-dihydroisobenzofuran

China 3-oxo-1,3-dihydroisobenzofuran Factory

In the past few years, our company absorbed and digested advanced technologies both at home and abroad. Meanwhile, our company staffs a team of experts devoted to the development of 3-oxo-1,3-dihydroisobenzofuran,CAS NO 61260-15-9,61260-15-9,Olaparib intermediate,Olaparib advance intermediate, For anyone who is fascinated in any items, be sure to truly feel totally free to speak to us for further more details or be sure to deliver us email immediately, we will reply you in 24 hrs as well as the most effective quotation will probably be provided.
3-oxo-1,3-dihydroisobenzofuran, We always insist on the management tenet of "Quality is first, Technology is basis, Honesty and Innovation".We've been able to develop new products and solutions continuously to a higher level to satisfy different needs of customers.

Related Products

Hot Products

  • lumateperone (Tosylate)

    lumateperone (Tosylate)

    Product Name:lumateperone (Tosylate)
    Molecular Formula:C31H36FN3O4S
    Molecular Weight;565.7
    CAS Registry Number;1187020-80-9
  • Anthranilic acid

    Anthranilic acid

    Product Name:Anthranilic acid
    Molecular Formula:C7H7NO2
    Molecular Weight:137.14
    CAS Registry Number:118-92-3
  • 3,5-Difluorobenzoic acid

    3,5-Difluorobenzoic acid

    Product Name:3,5-Difluorobenzoic acid
    Molecular Formula:C7H4F2O2
    Molecular Weight:158.1
    CAS Registry Number:455-40-3
  • 4-(3,4-Dichlorophenyl)-1-tetralone

    4-(3,4-Dichlorophenyl)-1-tetralone

    Product Name:4-(3,4-Dichlorophenyl)-1-tetralone
    Molecular Formula:C16H12Cl2O
    Molecular Weight:291.17
    CAS Registry Number:79560-19-3
  • 2-AMINO-5-BROMO-3-FLUOROBENZOIC ACID

    2-AMINO-5-BROMO-3-FLUOROBENZOIC ACID

    Product Name:2-AMINO-5-BROMO-3-FLUOROBENZOIC ACID
    Molecular Formula:C7H5BrFNO2
    Molecular Weight:234.02
    CAS Registry Number:874784-14-2
  • Camptothecin

    Camptothecin

    Product Name:Camptothecin
    Molecular Formula:C20H16N2O4
    Molecular Weight:348.35
    CAS Registry Number;7689-03-4
  • Related Blog
  • Reviews

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products can be produced in ordinary chemical plants without obtaining a pharmaceutical production license. As long as the technical indicators meet certain level requirements, they can be used to participate in the synthesis and production of drugs.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

    In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept